chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After initially receiving vaccine 12/28/2020 my arm was sore and slightly red for approx 2 days and resolved on 12/30/20. When I awoke this morning my right shoulder ached and I thought massage might make it feel better - at that time I noted it was swollen and warm tender to touch at site and again appeared red. I did report this to the clinic who administered vaccine
Local reaction L deltoid. Red with itching. Ice to area and 2 tsp Benadryl given po.
Soreness, redness and slight swelling of left nipple; Soreness, redness and slight swelling of left nipple; Soreness, redness and slight swelling of left nipple; This is a spontaneous report from a contactable consumer (patient). A 26-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EW0183, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 14May2021 09:00 (at the age of 26-years-old) as 2nd dose, single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient has no concomitant medications. The patient was previously vaccinated with the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: ER8736, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 21Apr2021 (at the age of 25-years-old) for COVID-19 immunisation. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. On 15May2021, the patient experienced soreness, redness, and slight swelling of left nipple. The events were assessed as non-serious. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering.
Events reported on 12/6/05. Following flu shot to left deltoid, patient complained of swelling and pain to left shoulder. Patient stated it was so painful I had to take Vicodin for a couple of weeks. Duration of severe pain approximately 2 weeks, though very painful for 4 weeks total. Seen by personal physician, MRI completed - normal. Full ROM to left shoulder.
Fever 100.4; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 100.4) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever 100.4). At the time of the report, PYREXIA (Fever 100.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 100.4 (High) Fever 100.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided.  Treatment information was not provided.
migratory arthralgias Intermittent muscle weakness in bilateral lower extremities shortness of breath
Information has been received from a physician concerning a 20 week old female with no known allergies or pertinent medical history who on approximately 01-JAN-2008 was vaccinated with a second dose of Rotateq.  On 15-JAN-2008 the patient had a seizure.  The patient was hospitalized.  MRI of the brain was negative, EEG was negative and unspecified blood work was negative.  There was no product quality complaint involved.  No further information was provided.  Additional information has been requested. Additional information from the physician indicated that no further information is available. Additional information is not expected.
Urticaria Pruritus & Mid-sternal chest tightness, itchiness
Received booster vaccine in October 2021. In November 2021 my blood pressure became high that I had to be put on two blood pressure medications. January 19,2022 I had a stroke. Multiple stokes according to MRI. They ran a bunch of tests and can not find out why I had a stroke. A year later in November 2022 my blood pressure came back to normal. My physicians is still keeping me on medications because they do not know why I had the stroke.
This initial spontaneous report was received on 18-SEP-2018 from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2013, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and indication not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 20-NOV-2016, the patient was treated at a medical office for a blistering vesicular outbreak that was diagnosed as a herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Seizure lasting approx. 1 minutes with 5 min post ictal period within 48 hrs of vaccine administration. No fever, negative bloodwork.
The patient was supposed to be administered a COVID-19 vaccine, but the administering technician grabbed a new syringe that had not been used to draw up medication yet, and placed that in the patient's arm. She stated that she was unable to push as there was no medication in the syringe.
This spontaneous report was received from an approximately 66 year old female consumer with diabetes refers to herself. The patient reported she could not take "SSRI drugs" because they caused her to have a stroke years ago. On an unspecified date in March 2014 (reported as the end of March 2014) the patient was vaccinated with "one shot" ZOSTAVAX (lot # not provided)  route reported as injection. Other suspect therapies included MYRBETRIQ. Concomitant therapies included atenolol, metoprolol, LEVIMIR, NOVOLOG and other unspecified medications. She reported that, on an unspecified date around the time that she received ZOSTAVAX, she "switched from metoprolol to atenolol in order to be able to start MYRBETIQ. She had since switched back to metoprolol instead of atenolol and also stopping taking MYRBETRIQ. On an unspecified date in April 2014 (reported as a few days after receiving ZOSTAVAX, the patient experienced injection site reaction of "swelling, hardness, warmth, and redness" which "lasted 2 weeks". She reported that she had been and was still experiencing other reactions which began after the injection site reaction appeared (onset dates unspecified). These other reactions include "extreme itching" which was "everywhere" on he body but which was most pronounced and persistent on her upper body and especially in the areas of her chest, arms, and stomach. She also reported "redness" or "flushing" in her neck and face which was accompanied by itching and which "happened toward the end of the day". Since having had ZOSTAVAX she was also "sensitive to the sun" and experiencing aching and pain in her joints and fingers. She stated that the adverse effects she was till experiencing "seems to be getting better" slowly. She sought medical attention by calling her physician only about the flushing and itching of her face and neck. She did not mention her other adverse effects to her physician. The flushing and itching of her face and neck was originally suspected to be a reaction to MYRBETRIQ, which she began taking on an unspecified date after receiving ZOSTAVAX. None treatment was given for the adverse effects. The relationship between the events and ZOSTAVAX was not reported. Additional information has been requested.
Felt achy and had pain on her; Constant pain; Felt achy; Diarrhea; Vertigo; A very bad cough; Arm was pretty sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (A very bad cough), VERTIGO (Vertigo), PAIN IN EXTREMITY (Arm was pretty sore), CHEST PAIN (Felt achy and had pain on her) and DIARRHOEA (Diarrhea) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia (Symptoms include tiredness, achiness, headaches, cognitive problems) and Asthma. Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) and PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was pretty sore). On 28-Jan-2021, the patient experienced COUGH (A very bad cough). On 04-Feb-2021, the patient experienced VERTIGO (Vertigo). On 06-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). On an unknown date, the patient experienced CHEST PAIN (Felt achy and had pain on her), PAIN (Constant pain) and MYALGIA (Felt achy). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of UNK dosage form; CODEINE for Cough, at a dose of UNK dosage form and LOPERAMIDE HYDROCHLORIDE (LOMOTIL [LOPERAMIDE HYDROCHLORIDE]) for Diarrhea, at a dose of UNK dosage form. On 29-Jan-2021, PAIN IN EXTREMITY (Arm was pretty sore) had resolved. At the time of the report, COUGH (A very bad cough), VERTIGO (Vertigo), CHEST PAIN (Felt achy and had pain on her), DIARRHOEA (Diarrhea), PAIN (Constant pain) and MYALGIA (Felt achy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included inhaler for her breathing. On 09 Mar 2021, the patient went to ENT doctor. The patient got tested with negative results. It was reported that it took eight weeks to get back to normal.   This case was linked to MOD-2021-040255 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Mar-2021: The patient historical condition updated. The event constant pain was added. The patient visit to doctor and testing details were added. On 21-Apr-2021: The event outcome updated as resolved.
Hives on neck/ chin area, nose & fingers, very itchy Swelling of lips & nose, tingly sensation
RUnny nose that evening after receiving vaccine which then turned into low grade fever and chills for about 5 days.  Incision sites also had a red ring around them as if I was allergic to the Vicryl sutures used during the surgery.  Also very tired and lethargic while exhibiting low grade fever as well.  I was taking Percocet for pain control from the procedure along with Motrin 400mg respectively.
Welt at her arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Welt at her arm at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE URTICARIA (Welt at her arm at injection site). At the time of the report, VACCINATION SITE URTICARIA (Welt at her arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt experienced erythema at the site of injection. Also felt a lump at site of injection. The site was hot, itchy and sore.
Diagnosed with Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with Covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced COVID-19 (Diagnosed with Covid). At the time of the report, COVID-19 (Diagnosed with Covid) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2020, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.; Reporter's Comments: This case concerns an adult female with nonserious unexpected event of COVID-19, and nonserious unexpected , and expected. Event onset 8 days after first dose mRNA-1273. Events resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
not immunocompromised, but got full dose of booster; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (not immunocompromised, but got full dose of booster) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939903, 011A21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 ml. On 30-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE (not immunocompromised, but got full dose of booster). On 30-Nov-2021, ACCIDENTAL OVERDOSE (not immunocompromised, but got full dose of booster) had resolved.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-402785 (Patient Link).
I tested positive 1/27/2022 for COVID19, that started with runny nose, congestion, slight cough, low grade temp, burning sensation in bilateral lower extremities. I did a Z-Pak of azithromycin, and a Medrol Dose Pak. Recovered with no lasting effects.
Cough, trouble breathing, congestion, sinus pressure and drainage, headache, fatigue.
Visual Impairment; Blurry vision; Balance difficulty; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (Visual Impairment), VISION BLURRED (Blurry vision), BALANCE DISORDER (Balance difficulty) and HEADACHE (Headache) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19.    Co-suspect product included non-company product COVID-19 VACCINE NRVV AD26 (JNJ 78436735) for an unknown indication.    No Medical History information was reported.   In March 2021, the patient started COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (unknown route) at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VISUAL IMPAIRMENT (Visual Impairment), VISION BLURRED (Blurry vision), BALANCE DISORDER (Balance difficulty) and HEADACHE (Headache). At the time of the report, VISUAL IMPAIRMENT (Visual Impairment), VISION BLURRED (Blurry vision), BALANCE DISORDER (Balance difficulty) and HEADACHE (Headache) outcome was unknown.            Patient felt the same reaction when he took Johnson and Johnson vaccine in march but these was much worse. No concomitant medication information was provided. No treatment medication were provided. Patient did not have any allergies.
Syncopal episode after injection. Prolonged lethargy and weakness following episode. Went to ER -seen by provider. Labs, EKG, 2 L NaCl given as treatment.
Pain began as a "crick" in the left side of the neck two days after receipt of second covid vaccine. It has now been three weeks and pain has been continuous in the left shoulder and left neck. Pain radiates down the arm and up into the ear, making the ear hurt and making it painful to swallow. The skin is also tender/painful to touch in the same areas, as if nerve damage has occurred. Swelling is visible in the upper back and neck.
Pt said immunization didn't hurt when administered but seemed to be given higher up on the shoulder than she normally gets shots.  Within a few hours her shoulder began hurting and is still painful to use.
Chicken pox type rash on legs and arms. Started 5/24/13, still experieincing 5/28/13 using BENADRYL and calamine lotion.
I developed a severe fever 103F or higher, it lasted for 2 straight days. I could not do anything because I had no energy. I had a severe headache beyond migraine level. I went to urgent care on the 2nd day and they prescribed me Ibuprofen and Tylenol, and told me it would pass. I have had breathing issues since this dose and they have not gotten better. I feel like it made my COPD worse.
At 4:00PM the same day that the  vaccine was administered; patient noticed a rash on his back. Patient took one dose of benadryl and the rash went away by that same evening. The following day at 10:30AM patient noticed his lips swelled. He took another dose of Benadryl and swelling of lips went away. His wife encouraged patient to call and report his side effects. Client is completely recovered from his side effects. He did not sign up for  and did not seek medical attention from his physician.
0.3mL of Pfizer vaccine was drawn and administered without diluent.  Patient received concentrated dose.   Medical director was notified and consulted.   Patient contacted about error, instructed to watch and seek medical care for severe reactions (heart or breathing problems) and to be aware of increased common side effects.  No immediate reaction was noted.
headache; muscle aches and pains; pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (pneumonia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced PNEUMONIA (pneumonia) (seriousness criterion medically significant). On an unknown date, the patient experienced HEADACHE (headache) and MYALGIA (muscle aches and pains). On 01-May-2021, PNEUMONIA (pneumonia) had resolved. At the time of the report, HEADACHE (headache) and MYALGIA (muscle aches and pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included IV (which may had antibiotics), doxycycline and its dose lasted till Wednesday last week (28Apr2021). Patient was not taking any other medications.  It was reported that on 14 Apr 2021, the patient had taken 1st dose of Moderna COVID-19 vaccine (Lot number 011M20A) in the right upper arm and 6 hours later patient was sick and had chills, fever. On 18 Apr 2021, the patient went to urgent care and diagnosed with pneumonia. On 01 May 2021 the event Pneumonia was resolved (Duration 14 days).  Patient was scheduled to get 2nd dose of vaccine on 12-May-2021.  Company Comment:  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
BLACKOUTS; DIZZINESS; FATIGUE; This spontaneous report received from a consumer concerned a 79 year old female. The patient's height, and weight were not reported. The patient's medical history included autoimmune disorder, and penicillin allergy. The patient experienced drug allergy when treated with azithromycin.  The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of admin not reported, batch number: 1805029 and expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 14:30 hours for prophylactic vaccination.  No concomitant medications were reported.  On 15-MAR-2021, the subject experienced blackouts, dizziness and fatigue.  Laboratory data (dates unspecified) included: IgG decreased (NR: not provided) unknown. The action taken with COVID-19 VACCINE AD26.COV2.S was not applicable. The patient was recovering from blackouts, and had not recovered from dizziness, and fatigue. The reporter causality between COVID-19 VACCINE AD26.COV2.S and blackouts, Dizziness and Fatigue was related. The company causality between COVID-19 VACCINE AD26.COV2.S and blackouts, Dizziness and Fatigue was possible. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210333795-covid-19 vaccine ad26.cov2.s-Loss of consciousness. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Information has been received from a male consumer with a history of shingles who in June 2006, was vaccinated with a dose of Zostavax. Concomitant therapy included famciclovir (FAMVIR). Since vaccination the patient experienced "2 outbreaks of shingles" in January 2007 and April 2007. Unspecified medical attention was sought. There was no product quality complaint involved. No further information is available.
severe abdominal pain, tremors, fainted twice. within 48 hours of vaccine receiving.  Also happened after having cajun foods.